Dr Reddy’s signals a sharp step up in ambitions at home, propelled by building leadership in 10 therapy segments and...
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's...
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a...
The French biotech's chances of competing with Aimmune's Palforzia in the peanut allergy market have been boosted after US regulators...
Ipsen’s business strategy calls for accessing external innovation across its pipeline, combined with geographic expansion, realizing the unmet potential of...
One year after the first cases of a novel coronavirus emerged in Wuhan, a team from the World Health Organization...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up...
Cipla sees an incremental revenue opportunity of up to $500m for its US franchise by fiscal 2025 and expects to...
After years of setbacks, Novavax is on the cusp of success with its COVID-19 vaccine - but a rapid scale...